6U3L
Crystal structure of Hemerythrin HHE cation binding domain-containing protein: Rv2633c homolog from Mycobacterium kansasii
Replaces: 6PIEExperimental procedure
| Experimental method | SINGLE WAVELENGTH | 
| Source type | SYNCHROTRON | 
| Source details | APS BEAMLINE 21-ID-F | 
| Synchrotron site | APS | 
| Beamline | 21-ID-F | 
| Temperature [K] | 100 | 
| Detector technology | CCD | 
| Collection date | 2010-03-21 | 
| Detector | RAYONIX MX-300 | 
| Wavelength(s) | 0.97872 | 
| Spacegroup name | P 31 2 1 | 
| Unit cell lengths | 52.050, 52.050, 104.700 | 
| Unit cell angles | 90.00, 90.00, 120.00 | 
Refinement procedure
| Resolution | 45.080 - 1.750 | 
| R-factor | 0.1819 | 
| Rwork | 0.178 | 
| R-free | 0.21790 | 
| Structure solution method | SAD | 
| RMSD bond length | 0.008 | 
| RMSD bond angle | 0.851 | 
| Data reduction software | XDS | 
| Data scaling software | XSCALE | 
| Phasing software | PHASER | 
| Refinement software | PHENIX | 
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 50.000 | 50.000 | 1.800 | 
| High resolution limit [Å] | 1.750 | 7.830 | 1.750 | 
| Rmerge | 0.041 | 0.020 | 0.639 | 
| Rmeas | 0.044 | 0.022 | 0.716 | 
| Number of reflections | 17189 | 234 | 1264 | 
| <I/σ(I)> | 24.94 | 62.2 | 2.18 | 
| Completeness [%] | 100.0 | 98.7 | 99.9 | 
| Redundancy | 6.91 | 5.615 | 4.944 | 
| CC(1/2) | 1.000 | 0.999 | 0.850 | 
Crystallization Conditions
| crystal ID | method | pH | temperature | details | 
| 1 | VAPOR DIFFUSION, SITTING DROP | 290 | MCSG-1 screen F3: 200mM ammonium citrate, 25% PEG 3350: MykaA.20209.a.B11.PB00101 at 2mg/ml, grown at 14C: cryo: 20% EG: tray 308332F3: puck vlf8-4. For experimental phasing, a crystal from MCSG-1 screen, condition F3 (200mM ammonium citrate, 25% PEG 3350) with MykaA.20209.a B1.PB00101 at 3mg/ml, grown at 14C, was incubated for 15 sec each in a solution of 90% reservoir and 10% 2.5M sodium iodide in ethylene glycol, and then in a solution of 80% reservoir and 20% 2.5M sodium iodide in ethylene glycol, and vitrified in liquid nitrogen: tray 308326f3: puck fdn8-5 | |
| 1 | VAPOR DIFFUSION, SITTING DROP | 290 | MCSG-1 screen F3: 200mM ammonium citrate, 25% PEG 3350: MykaA.20209.a.B11.PB00101 at 2mg/ml, grown at 14C: cryo: 20% EG: tray 308332F3: puck vlf8-4. For experimental phasing, a crystal from MCSG-1 screen, condition F3 (200mM ammonium citrate, 25% PEG 3350) with MykaA.20209.a B1.PB00101 at 3mg/ml, grown at 14C, was incubated for 15 sec each in a solution of 90% reservoir and 10% 2.5M sodium iodide in ethylene glycol, and then in a solution of 80% reservoir and 20% 2.5M sodium iodide in ethylene glycol, and vitrified in liquid nitrogen: tray 308326f3: puck fdn8-5 | 






